Now, things finally seem to be ramping up again, and the UK’s fast becoming a world centre for research thanks to regulators that are increasingly willing to approve trials, and the recent introduction of a special pathway designed to bring innovative therapies to market more quickly. Clerkenwell Health’s new lab near Harley Street will work with drug companies around the world, including Toronto’s Psyence, Canada’s Mindset Pharma and US-based Mydecine, to tackle problems like end-of-life anxiety, psychiatric disorders and even nicotine addiction.